Perennial Investment Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$204K Sell
2,842
-61
-2% -$4.7K 0.02% 479
2025
Q4
$230K Buy
2,903
+149
+5% +$11.7K 0.02% 438
2025
Q3
$208K Buy
+2,754
New +$189K 0.02% 460
2024
Q1
Sell
-2,698
Closed -$213K 368
2023
Q4
$213K Sell
2,698
-189
-7% -$13.5K 0.04% 300
2023
Q3
$202K Buy
+2,887
New +$205K 0.04% 310
2023
Q2
Sell
-3,722
Closed -$277K 368
2023
Q1
$277K Sell
3,722
-545
-13% -$45.7K 0.05% 254
2022
Q4
$398K Buy
4,267
+599
+16% +$57.8K 0.16% 124
2022
Q3
$350K Buy
3,668
+221
+6% +$21.9K 0.16% 116
2022
Q2
$320K Buy
3,447
+17
+0.5% +$1.66K 0.13% 135
2022
Q1
$347K Sell
3,430
-842
-20% -$88.5K 0.11% 147
2021
Q4
$440K Sell
4,272
-168
-4% -$15.5K 0.14% 133
2021
Q3
$376K Buy
4,440
+772
+21% +$64.7K 0.13% 138
2021
Q2
$306K Buy
+3,668
New +$300K 0.11% 155

Other funds holding CVS

Perennial Investment Advisors's CVS Position: Q1 2026 in Review

Perennial Investment Advisors reduced its CVS Health (CVS) stake by 2.1% in Q1 2026, selling an estimated $4.7K and leaving 2,842 shares worth $204K. The position accounts for 0.02% of the portfolio, ranked #479.

Perennial Investment Advisors first reported a position in CVS in Q2 2021 and has held it in 13 quarters since. The position peaked at $440K in Q4 2021. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Perennial Investment Advisors held 2,842 shares of CVS Health worth $204K as of Q1 2026.
  • Perennial Investment Advisors sold 61 CVS Health shares in Q1 2026, an estimated $4.7K.
  • CVS Health made up 0.02% of Perennial Investment Advisors's portfolio in Q1 2026, its #479 holding.
  • Perennial Investment Advisors first reported a position in CVS Health in Q2 2021 and has held it in 13 quarters since.
  • Perennial Investment Advisors's CVS Health position peaked at $440K in Q4 2021.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Perennial Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.